Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound astragalus polysaccharide granule for preventing and treating avian influenza

A technology of astragalus polysaccharides and compound recipes, which is applied in the field of compound astragalus polysaccharide granule combination medicine for preventing and treating chicken avian influenza and its preparation field

Pending Publication Date: 2021-12-31
河南纳瑞森生物药业有限公司 +2
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In view of the above situation, in order to solve the defects of the prior art, the object of the present invention is to provide a compound astragalus polysaccharide granule for preventing and treating bird flu in chickens, which can effectively solve the problem of medication for preventing and treating bird flu in chickens.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound astragalus polysaccharide granule for preventing and treating avian influenza
  • Compound astragalus polysaccharide granule for preventing and treating avian influenza

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0016] When the present invention is implemented, it is calculated by the following weight: 3. The compound astragalus polysaccharide granule of the present invention described in right 1 is characterized in that it is calculated by the following weight: 20 parts of Radix Astragali, 10 parts of Flos Lonicerae, Radix Radix Radix 15 parts, 10 parts of Achyranthes bidentata, 10 parts of Angelica sinensis, 10 parts of forsythia, 20 parts of cat's claw and 5 parts of selenium japonicus were used as raw materials, and the finished product was prepared according to the steps described in the technical scheme.

example 2

[0018] When the present invention is implemented, it is calculated by the following weights: 30 parts of Radix Astragali, 20 parts of Flos Lonicerae, 35 parts of Radix Isatidis, 20 parts of Achyranthes bidentata, 20 parts of Angelica sinensis, 30 parts of Forsythia, 30 parts of Cat's Claw and the kernel 15 parts are used as raw materials. The finished product is prepared according to the steps described in the technical scheme.

example 3

[0020] When the present invention is implemented, it is calculated by the following weights: 25 parts of Radix Astragali, 15 parts of Flos Lonicerae, 25 parts of Radix Isatidis, 15 parts of Achyranthes bidentata, 15 parts of Angelica sinensis, 20 parts of Forsythia, 25 parts of Cat's Claw and the kernel 10 parts are used as raw materials. The finished product is prepared according to the steps described in the technical scheme.

[0021] Each composition formula solution in the above-mentioned prescription of the present invention:

[0022] The composition of compound astragalus polysaccharide granules is: astragalus, honeysuckle, isatis root, achyranthes bidentata, angelica, forsythia, cat's claw and wood turtle:

[0023] Astragalus: In recent years, studies have found that Astragalus contains polysaccharides, saponins, flavonoids, amino acids, trace elements and other active ingredients. These active ingredients have the effect of promoting antibody production and immune res...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound astragalus polysaccharide granule for preventing and treating avian influenza, which can effectively solve the problem of drug use for avian influenza, and adopts the technical scheme that the compound astragalus polysaccharide granule is prepared from the following raw material drugs in parts by weight: 20-30 parts of astragalus, 10-20 parts of honeysuckle, 15-35 parts of radix isatidis, 10-20 parts of radix achyranthis bidentatae, 10-20 parts of angelica sinensis, 10-30 parts of fructus forsythiae, 20-30 parts of radix ranunculi ternati and 5-15 parts of semen momordicae, and after the raw material drugs are extracted and concentrated by adopting the modern process, and auxiliary materials are added to prepare granules, wherein auxiliary materials are one or mixture of more than two of starch, powdered sugar and dextrin. According to the compound astragalus polysaccharide granule, the raw materials are rich, the price is low, the medication is safe, no irritation or toxic-side effect is generated on poultry, the bird flu prevention and treatment effect on poultry is good, the compound astragalus polysaccharide granule is good in use effect, and is an innovation of traditional Chinese veterinary medicines for preventing and treating avian influenza. Meanwhile, the preparation method is simple, the cost is low, the use is convenient, the prevention effect on the bird flu of poultry is very good, and the compound astragalus polysaccharide granule is suitable for large-scale popularization and application.

Description

technical field [0001] The invention belongs to the technical field of pharmacy, and in particular relates to a compound astragalus polysaccharide granule combination medicine for preventing and treating avian influenza in chickens and a preparation method thereof. Background technique [0002] Avian influenza is the abbreviation of avian influenza. The pathogenesis of chicken avian influenza is characterized by: ① complex clinical symptoms, often mixed with bronchitis, pharyngitis, colibacillosis, etc. clinically; ② morbidity and mortality and strain, Chicken sex, environment and complications are related to secondary infection. For example, avian influenza virus invades the mucous membrane, which is conducive to the secondary colibacillosis, strengthens the hemagglutinin effect of avian influenza virus, and leads to increased morbidity and mortality in chicken flocks;③ There are many serotypes of avian influenza virus, and the cross-protection among various types is weak, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/71A61K9/16A61P31/16C08B37/00A61K31/715
CPCA61K36/481A61K36/355A61K36/195A61K36/315A61K36/21A61K36/232A61K36/634A61K36/71A61K36/42A61K31/715A61K9/1652A61P31/16C08B37/0003A61K2236/331A61K2236/39A61K2236/51A61K2236/333A61K2236/53A61K2236/31A61K2300/00
Inventor 杨成祥赵云生赵蕾范新蕾司俊伟孟令昭
Owner 河南纳瑞森生物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products